At the news
? NEUTRALIMPACT 1/10 PRESS-RELEASE filed Nov 4, 2026 at 16:01 ET
Praxis Precision Medicines granted 23,219 restricted stock units to 59 new non-executive employees under its 2024 Inducement Plan, as inducements material to their employment. The awards vest over four years. This is a routine equity grant for new hires, immaterial relative to the company's $7.6B market cap.
- 23,219 restricted stock units granted to 59 new non-executive employees
- Awards vest in four equal annual installments
- Granted under the 2024 Inducement Plan per Nasdaq Listing Rule 5635(c)(4)
- Company market cap is $7.6B, making the grant de minimis
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access